JP2006505575A5 - - Google Patents

Download PDF

Info

Publication number
JP2006505575A5
JP2006505575A5 JP2004545990A JP2004545990A JP2006505575A5 JP 2006505575 A5 JP2006505575 A5 JP 2006505575A5 JP 2004545990 A JP2004545990 A JP 2004545990A JP 2004545990 A JP2004545990 A JP 2004545990A JP 2006505575 A5 JP2006505575 A5 JP 2006505575A5
Authority
JP
Japan
Prior art keywords
fluorobenzyl
chloro
oxopropenyl
methylpiperazin
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004545990A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505575A (ja
Filing date
Publication date
Priority claimed from GBGB0224917.5A external-priority patent/GB0224917D0/en
Application filed filed Critical
Publication of JP2006505575A publication Critical patent/JP2006505575A/ja
Publication of JP2006505575A5 publication Critical patent/JP2006505575A5/ja
Pending legal-status Critical Current

Links

JP2004545990A 2002-10-25 2003-10-24 1−(4−ベンジルピペラジン−1−イル)−3−フェニルプロペノン誘導体 Pending JP2006505575A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0224917.5A GB0224917D0 (en) 2002-10-25 2002-10-25 Organic compounds
PCT/EP2003/011848 WO2004037796A2 (en) 2002-10-25 2003-10-24 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives

Publications (2)

Publication Number Publication Date
JP2006505575A JP2006505575A (ja) 2006-02-16
JP2006505575A5 true JP2006505575A5 (https=) 2010-10-28

Family

ID=9946616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004545990A Pending JP2006505575A (ja) 2002-10-25 2003-10-24 1−(4−ベンジルピペラジン−1−イル)−3−フェニルプロペノン誘導体

Country Status (19)

Country Link
US (1) US7645760B2 (https=)
EP (1) EP1558594A2 (https=)
JP (1) JP2006505575A (https=)
KR (1) KR20050065620A (https=)
CN (2) CN100554257C (https=)
AR (1) AR043055A1 (https=)
AU (1) AU2003296559B2 (https=)
BR (1) BR0315662A (https=)
CA (1) CA2502633C (https=)
EC (1) ECSP055745A (https=)
GB (1) GB0224917D0 (https=)
MX (1) MXPA05004348A (https=)
NO (1) NO20052487L (https=)
PE (1) PE20040779A1 (https=)
PL (1) PL374893A1 (https=)
RU (1) RU2347782C2 (https=)
TW (1) TW200420545A (https=)
WO (1) WO2004037796A2 (https=)
ZA (1) ZA200502700B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7456184B2 (en) * 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
SE0400441D0 (sv) 2004-02-25 2004-02-25 Active Biotech Ab Novel Benzofurans and Indols
SE0400440D0 (sv) * 2004-02-25 2004-02-25 Active Biotech Ab Novel Cinnamic Amides
GB0409236D0 (en) * 2004-04-26 2004-05-26 Novartis Ag Organic compounds
US7777035B2 (en) 2005-06-22 2010-08-17 Chemocentryx, Inc. Azaindazole compounds and methods of use
CN101007794B (zh) * 2006-01-26 2010-09-01 中国科学院上海药物研究所 N,n'-二取代哌嗪类衍生物及其制备方法、药物组合物和用途
US7601844B2 (en) 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
US7615556B2 (en) 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
FR2902426B1 (fr) * 2006-06-19 2008-09-05 Pierre Fabre Medicament Sa Derives de cinnamoyl-piperazine
WO2008090357A2 (en) * 2007-01-24 2008-07-31 Palatin Technologies, Inc. N, n; -substituted piperazines binding to melanocortin receptor
TWI433838B (zh) 2008-06-25 2014-04-11 必治妥美雅史谷比公司 作為趨化因子受體活性調節劑之六氫吡啶衍生物
HRP20141190T1 (hr) * 2010-01-29 2015-01-30 Otsuka Pharmaceutical Co., Ltd. Disupstituirani derivati piridina kao antikancerogena sredstva
US8642622B2 (en) 2010-06-16 2014-02-04 Bristol-Myers Squibb Company Piperidinyl compound as a modulator of chemokine receptor activity
ES2682217T3 (es) 2012-08-08 2018-09-19 Mitsubishi Tanabe Pharma Corporation Método para producir un compuesto de 1,4-benzoxazina
US9993497B2 (en) * 2012-12-30 2018-06-12 Hadasit Medical Research Services And Development Ltd. Use of alginate compositions in preventing or reducing liver damage caused by a hepatotoxic agent
AP2016009020A0 (en) * 2013-07-18 2016-02-29 Novartis Ag Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
WO2015048570A2 (en) * 2013-09-26 2015-04-02 Sanford-Burnham Medical Research Institute Ebi2 modulators
WO2016116875A1 (en) * 2015-01-20 2016-07-28 Novartis Ag Pet imaging agents
EP4065112A4 (en) * 2019-11-22 2023-12-27 The Regents of the University of California Taspase1 inhibitors and uses thereof
US20230062100A1 (en) 2019-11-28 2023-03-02 Bayer Aktiengesellschaft Substituted aminoquinolones as dgkalpha inhibitors for immune activation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60139646A (ja) * 1983-12-27 1985-07-24 Otsuka Pharmaceut Factory Inc ナフタレン誘導体
JPS6219577A (ja) * 1985-07-16 1987-01-28 Kanebo Ltd 新規なベンジルピペラジン誘導体および該化合物を有効成分とする医薬組成物
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
SE9201956D0 (sv) * 1992-06-25 1992-06-25 Kabi Pharmacia Ab Novel nicotinicacid esters
US5380726A (en) * 1993-01-15 1995-01-10 Ciba-Geigy Corporation Substituted dialkylthio ethers
FR2725445B1 (fr) * 1994-10-10 1996-10-31 Adir Nouveaux derives a structure 1-arylalkenyl 4-aryl alkyl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2000086603A (ja) * 1998-07-15 2000-03-28 Yoshitomi Pharmaceut Ind Ltd 桂皮酸アミド誘導体および3―フェニルプロピオン酸アミド誘導体
US6110922A (en) * 1998-12-29 2000-08-29 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
OA12670A (en) * 2001-10-22 2006-06-20 Pfizer Prod Inc Piperazine derivatives with ccr1 receptor antagonist activity.

Similar Documents

Publication Publication Date Title
JP2006505575A5 (https=)
TWI326681B (en) 4,4,5,5 tetrasubstituted imidazolines
CA2429844C (en) Mch antagonists and their use in the treatment of obesity
JP4853965B2 (ja) アダマンタン誘導体およびアザビシクロオクタン誘導体およびアザビシクロノナン誘導体、ならびにこれらの調製方法およびdpp−iv阻害剤としてのこれらの使用
US8017607B2 (en) N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions
CN100390149C (zh) 吲唑衍生物
US5202344A (en) N-substituted lactams useful as cholecystokinin antagonists
AU2004247487B2 (en) N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
JP2004505070A (ja) カルボキサミド化合物およびそれらのヒト11cby受容体アンタゴニストとしての使用
WO2021204823A1 (en) (1 h-indol-5-yl)acrylamide derivatives as inhibitors of tead proteins and the hippo-yap1/taz signaling cascade for the treatment of cancer
ZA200502700B (en) 1-(4-benzyl-piperazin-1-YL)-3-phenyl-propenone derivatives.
WO2002018321A2 (en) Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
JP2000344741A (ja) タキキニンアンタゴニストとしての3−アゼチジニルアルキルピペリジンまたは−ピロリジン
JPH0873439A (ja) 1−ベンジル−1,3−ジヒドロ−2h−ベンズイミダゾール−2−オン誘導体、これらの調製およびこれらを含有する薬学的組成物
KR20100055469A (ko) 신규 화합물
WO2005012258A1 (ja) タンパク質キナーゼ阻害剤
CA1332835C (en) Aliphatic carboxamides
WO2005014580A1 (en) Pyridyl piperazinyl ureas
PT1751093E (pt) Derivados de ácido ciclo-hexilacético substituídos
CA2450271A1 (en) Novel phenylalkyl diamine and amide analogs
IE44765B1 (en) Benzamide derivatives
JP2001502348A (ja) 金属タンパク質分解酵素阻害剤
JPWO1994002472A1 (ja) チアゾリン誘導体
WO2009021945A1 (de) Arylsulfonamide mit analgetischer wirkung
EA015419B1 (ru) Новые производные фенантридина в качестве антагонистов брадикинина